ENGASE

Chr 17

endo-beta-N-acetylglucosaminidase

The encoded cytosolic endoglycosidase cleaves N-glycans from glycoproteins by hydrolyzing the beta-1,4-glycosidic bond in the N,N'-diacetylchitobiose core and processes free oligosaccharides in the cytosol. Mutations in ENGASE have not been established to cause human disease. The gene appears tolerant to loss-of-function variants based on constraint metrics.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
0
P/LP submissions
P/LP missense
1.34
LOEUF
Mechanism
Clinical SummaryENGASE
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
Some data sources returned errors (1)

ncbi: Error: NCBI fetch failed: 429 https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.34LOEUF
pLI 0.000
Z-score -0.09
OE 1.02 (0.781.34)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.02Z-score
OE missense 1.00 (0.931.08)
451 obs / 449.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE1.02 (0.781.34)
00.351.4
Missense OE1.00 (0.931.08)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 37 / 36.4Missense obs/exp: 451 / 449.8Syn Z: -0.51

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

ENGASE · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →